Medikaloka Hermina Tbk PT
IDX:HEAL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 070
1 595
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Medikaloka Hermina Tbk PT
Net Margin
Medikaloka Hermina Tbk PT
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | ID |
| Market Cap | 20.8T IDR |
| Net Margin |
8%
|
| Country | US |
| Market Cap | 83.9B USD |
| Net Margin |
9%
|
| Country | SA |
| Market Cap | 98B SAR |
| Net Margin |
22%
|
| Country | ZA |
| Market Cap | 24.9B Zac |
| Net Margin |
17%
|
| Country | ZA |
| Market Cap | 20.7B Zac |
| Net Margin |
5%
|
| Country | CN |
| Market Cap | 133.2B CNY |
| Net Margin |
18%
|
| Country | MY |
| Market Cap | 63.3B MYR |
| Net Margin |
11%
|
| Country | US |
| Market Cap | 13.7B USD |
| Net Margin |
15%
|
| Country | US |
| Market Cap | 13.1B USD |
| Net Margin |
7%
|
| Country | TH |
| Market Cap | 421.1B THB |
| Net Margin |
15%
|
| Country | IN |
| Market Cap | 997.2B INR |
| Net Margin |
5%
|
Medikaloka Hermina Tbk PT
Glance View
PT Medikaloka Hermina engages in healthcare services. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 15,086 full-time employees. The company went IPO on 2018-05-16. The firm is focused on providing services for BPJS patients to support government program in Indonesia. The Company’s services include hospitals, specialties and featured services. The Company’s hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology and surgery. The Company’s subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Medikaloka Hermina Tbk PT's most recent financial statements, the company has Net Margin of 8.5%.
You don't have any saved screeners yet
